Emre Yekedüz

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Drug Administration

Coronavirus Disease

Metastatic Colorectal Cancer

Top Venues

Future oncology (London, England)

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Future virology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Beliz Bahar Karaoğlan, Emre Yekedüz, Satı Coşkun Yazgan, Eda Eylemer Mocan, Elif Berna Koksoy, Hatime Arzu Yasar, Filiz Çay Şenler, Gungor Utkan, Ahmet Demirkazık, Hakan Akbulut, Yuksel Urun
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors. Immunotherapy (2024)
Emre Yekedüz, Elif Gizem Aktaş, Elif Berna Koksoy, Neslihan Doğan, Yuksel Urun, Gungor Utkan
The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. Future oncology (London, England) 18 (9) (2022)
Emre Yekedüz, Ömer Dizdar, Neyran Kertmen, Sercan Aksoy
Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer. Journal of clinical medicine 11 (9) (2022)
Emre Yekedüz, Güngör Utkan, Yuksel Urun
Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. Future oncology (London, England) 18 (4) (2022)
Elif Sertesen, Emre Yekedüz, Elif Berna Köksoy, Yüksel Ürün, Ayhan Bülent Erkek, Salim Demirci, Ali Ekrem Ünal, Güngör Utkan
The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab-containing regimens. ANZ journal of surgery (2022)
Emre Yekedüz, Dario Trapani, Wenxin Xu, Elisabeth G E de Vries, Chris Labaki, Bishal Gyawali, Shuchi Gulati, Chadi Nabhan, Güngör Utkan, Giuseppe Curigliano, Toni K Choueiri, Yuksel Urun
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. International journal of cancer 149 (7) (2021)
Emre Yekedüz, İsmail Ertürk, Deniz Tural, Nuri Karadurmus, Serdar Karakaya, Mutlu Hizal, Rukiye Arıkan, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Ozlem Nuray Sever, Gokhan Ucar, Orçun Can, Mehmet Ali Nahit Şendur, Umut Demirci, Saadettin Kılıçkap, Irfan Cicin, Ömür Berna Çakmak Öksüzoğlu, Mustafa Özgüroğlu, Yuksel Urun
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Future oncology (London, England) 17 (35) (2021)
Emre Yekedüz, İzzet Dogan, Dılşa Mızrak Kaya, İlker Özgür, Güngör Utkan, Sezai Vatansever, Salim Demirci, Hakan Akbulut, Yüksel Ürün
Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. Journal of gastrointestinal cancer (2021)
Emre Yekedüz, Güngör Utkan, Yuksel Urun
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (2) (2021)
Emre Yekedüz, Ruveyda Ayasun, Elif Berna Koksoy, Gungor Utkan, Yuksel Urun, Hakan Akbulut
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors. Future virology (2021)
Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, Güngör Utkan, Yuksel Urun
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2020)
Emre Yekedüz, Ayşe Müge Karcıoğlu, Gungor Utkan, Yuksel Urun
A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? Future oncology (London, England) 16 (25) (2020)
Emre Yekedüz, Elif Berna Koksoy, Hakan Akbulut, Yuksel Urun, Gungor Utkan
ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis. Future oncology (London, England) 17 (3) (2020)
Deniz Can Guven, Omer Dizdar, Abdullah Cevdet Akman, Ezel Berker, Emre Yekedüz, Furkan Ceylan, Batuhan Başpinar, İlgın Akbıyık, Burak Yasin Aktaş, Deniz Yuce, Mustafa Erman, Mutlu Kadir Hayran
Evaluation of cancer risk in patients with periodontal diseases Turkish journal of medical sciences 49 (3) (2019)